Morgan Stanley’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$128 Hold
144
﹤0.01% 7620
2025
Q1
$75 Hold
144
﹤0.01% 7622
2024
Q4
$73 Sell
144
-376
-72% -$191 ﹤0.01% 7518
2024
Q3
$1.84K Sell
520
-400
-43% -$1.42K ﹤0.01% 7145
2024
Q2
$7.28K Sell
920
-30
-3% -$237 ﹤0.01% 6762
2024
Q1
$12.9K Sell
950
-150
-14% -$2.03K ﹤0.01% 6607
2023
Q4
$11.9K Buy
1,100
+500
+83% +$5.41K ﹤0.01% 6793
2023
Q3
$3.9K Hold
600
﹤0.01% 6972
2023
Q2
$10.8K Sell
600
-145
-19% -$2.61K ﹤0.01% 6790
2023
Q1
$17.5K Sell
745
-34
-4% -$799 ﹤0.01% 6674
2022
Q4
$19.5K Buy
779
+381
+96% +$9.53K ﹤0.01% 6704
2022
Q3
$13K Sell
398
-399
-50% -$13K ﹤0.01% 6984
2022
Q2
$31K Sell
797
-262
-25% -$10.2K ﹤0.01% 6822
2022
Q1
$43K Sell
1,059
-371
-26% -$15.1K ﹤0.01% 6780
2021
Q4
$72K Buy
1,430
+341
+31% +$17.2K ﹤0.01% 6624
2021
Q3
$71K Buy
1,089
+43
+4% +$2.8K ﹤0.01% 6552
2021
Q2
$41K Buy
1,046
+257
+33% +$10.1K ﹤0.01% 6748
2021
Q1
$42K Buy
789
+5
+0.6% +$266 ﹤0.01% 6429
2020
Q4
$54K Buy
784
+184
+31% +$12.7K ﹤0.01% 6141
2020
Q3
$23K Buy
600
+443
+282% +$17K ﹤0.01% 6008
2020
Q2
$6K Sell
157
-14,137
-99% -$540K ﹤0.01% 6276
2020
Q1
$429K Buy
14,294
+13,948
+4,031% +$419K ﹤0.01% 4464
2019
Q4
$39K Buy
+346
New +$39K ﹤0.01% 5929
2019
Q3
Sell
-20
Closed -$1K 6705
2019
Q2
$1K Hold
20
﹤0.01% 6554
2019
Q1
$1K Sell
20
-20
-50% -$1K ﹤0.01% 6523
2018
Q4
$2K Hold
40
﹤0.01% 6420
2018
Q3
$2K Sell
40
-6,377
-99% -$319K ﹤0.01% 6579
2018
Q2
$139K Buy
6,417
+3,374
+111% +$73.1K ﹤0.01% 5659
2018
Q1
$116K Buy
3,043
+387
+15% +$14.8K ﹤0.01% 5661
2017
Q4
$154K Buy
2,656
+480
+22% +$27.8K ﹤0.01% 5502
2017
Q3
$143K Buy
2,176
+1,177
+118% +$77.3K ﹤0.01% 5474
2017
Q2
$85K Sell
999
-1,167
-54% -$99.3K ﹤0.01% 5694
2017
Q1
$300K Buy
+2,166
New +$300K ﹤0.01% 5116